 | • レポートコード：D005-00796 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、小児神経芽細胞腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。小児神経芽細胞腫治療の種類別市場規模（免疫療法、化学療法、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：United Therapeutics、Bayer、Apeiron Biologics、MacroGenics、Pfizer、Cellectar Biosciences、Baxter ・地域別グローバル市場分析 2015年-2020年 ・小児神経芽細胞腫治療の北米市場（アメリカ、カナダ、メキシコ） ・小児神経芽細胞腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・小児神経芽細胞腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・小児神経芽細胞腫治療の南米市場（ブラジル、アルゼンチン） ・小児神経芽細胞腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫療法、化学療法、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pediatric Neuroblastoma Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.8% in the forecast period of 2020 to 2025 and will expected to reach USD 724.1 million by 2025, from USD 599.6 million in 2019.
The Pediatric Neuroblastoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pediatric Neuroblastoma Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pediatric Neuroblastoma Treatment market has been segmented into:
Immunotherapy
Chemotherapy
Others
By Application, Pediatric Neuroblastoma Treatment has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pediatric Neuroblastoma Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Pediatric Neuroblastoma Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pediatric Neuroblastoma Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Pediatric Neuroblastoma Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Pediatric Neuroblastoma Treatment Market Share Analysis
Pediatric Neuroblastoma Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pediatric Neuroblastoma Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pediatric Neuroblastoma Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Pediatric Neuroblastoma Treatment are:
United Therapeutics
Bayer
Apeiron Biologics
MacroGenics
Pfizer
Cellectar Biosciences
Baxter
Table of Contents
1 Pediatric Neuroblastoma Treatment Market Overview
1.1 Product Overview and Scope of Pediatric Neuroblastoma Treatment
1.2 Classification of Pediatric Neuroblastoma Treatment by Type
1.2.1 Global Pediatric Neuroblastoma Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type in 2019
1.2.3 Immunotherapy
1.2.4 Chemotherapy
1.2.5 Others
1.3 Global Pediatric Neuroblastoma Treatment Market by Application
1.3.1 Overview: Global Pediatric Neuroblastoma Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Pediatric Neuroblastoma Treatment Market by Regions
1.4.1 Global Pediatric Neuroblastoma Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pediatric Neuroblastoma Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pediatric Neuroblastoma Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pediatric Neuroblastoma Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pediatric Neuroblastoma Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pediatric Neuroblastoma Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pediatric Neuroblastoma Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 United Therapeutics
2.1.1 United Therapeutics Details
2.1.2 United Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 United Therapeutics SWOT Analysis
2.1.4 United Therapeutics Product and Services
2.1.5 United Therapeutics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer SWOT Analysis
2.2.4 Bayer Product and Services
2.2.5 Bayer Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Apeiron Biologics
2.3.1 Apeiron Biologics Details
2.3.2 Apeiron Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Apeiron Biologics SWOT Analysis
2.3.4 Apeiron Biologics Product and Services
2.3.5 Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 MacroGenics
2.4.1 MacroGenics Details
2.4.2 MacroGenics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 MacroGenics SWOT Analysis
2.4.4 MacroGenics Product and Services
2.4.5 MacroGenics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Cellectar Biosciences
2.6.1 Cellectar Biosciences Details
2.6.2 Cellectar Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Cellectar Biosciences SWOT Analysis
2.6.4 Cellectar Biosciences Product and Services
2.6.5 Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Baxter
2.7.1 Baxter Details
2.7.2 Baxter Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Baxter SWOT Analysis
2.7.4 Baxter Product and Services
2.7.5 Baxter Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pediatric Neuroblastoma Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pediatric Neuroblastoma Treatment Players Market Share
3.2.2 Top 10 Pediatric Neuroblastoma Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pediatric Neuroblastoma Treatment Revenue and Market Share by Regions
4.2 North America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
5 North America Pediatric Neuroblastoma Treatment Revenue by Countries
5.1 North America Pediatric Neuroblastoma Treatment Revenue by Countries (2015-2020)
5.2 USA Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
6 Europe Pediatric Neuroblastoma Treatment Revenue by Countries
6.1 Europe Pediatric Neuroblastoma Treatment Revenue by Countries (2015-2020)
6.2 Germany Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
6.4 France Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue by Countries
7.1 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue by Countries (2015-2020)
7.2 China Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
7.5 India Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
8 South America Pediatric Neuroblastoma Treatment Revenue by Countries
8.1 South America Pediatric Neuroblastoma Treatment Revenue by Countries (2015-2020)
8.2 Brazil Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pediatric Neuroblastoma Treatment by Countries
9.1 Middle East & Africa Pediatric Neuroblastoma Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pediatric Neuroblastoma Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Pediatric Neuroblastoma Treatment Market Forecast by Type (2019-2024)
10.3 Immunotherapy Revenue Growth Rate (2015-2025)
10.4 Chemotherapy Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Pediatric Neuroblastoma Treatment Market Segment by Application
11.1 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2015-2020)
11.2 Pediatric Neuroblastoma Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Pediatric Neuroblastoma Treatment Market Size Forecast (2021-2025)
12.1 Global Pediatric Neuroblastoma Treatment Market Size Forecast (2021-2025)
12.2 Global Pediatric Neuroblastoma Treatment Market Forecast by Regions (2021-2025)
12.3 North America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
12.6 South America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Pediatric Neuroblastoma Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pediatric Neuroblastoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pediatric Neuroblastoma Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pediatric Neuroblastoma Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. United Therapeutics Corporate Information, Location and Competitors
Table 6. United Therapeutics Pediatric Neuroblastoma Treatment Major Business
Table 7. United Therapeutics Pediatric Neuroblastoma Treatment Total Revenue (USD Million) (2017-2018)
Table 8. United Therapeutics SWOT Analysis
Table 9. United Therapeutics Pediatric Neuroblastoma Treatment Product and Solutions
Table 10. United Therapeutics Pediatric Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bayer Corporate Information, Location and Competitors
Table 12. Bayer Pediatric Neuroblastoma Treatment Major Business
Table 13. Bayer Pediatric Neuroblastoma Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Bayer SWOT Analysis
Table 15. Bayer Pediatric Neuroblastoma Treatment Product and Solutions
Table 16. Bayer Pediatric Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Apeiron Biologics Corporate Information, Location and Competitors
Table 18. Apeiron Biologics Pediatric Neuroblastoma Treatment Major Business
Table 19. Apeiron Biologics Pediatric Neuroblastoma Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Apeiron Biologics SWOT Analysis
Table 21. Apeiron Biologics Pediatric Neuroblastoma Treatment Product and Solutions
Table 22. Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. MacroGenics Corporate Information, Location and Competitors
Table 24. MacroGenics Pediatric Neuroblastoma Treatment Major Business
Table 25. MacroGenics Pediatric Neuroblastoma Treatment Total Revenue (USD Million) (2017-2018)
Table 26. MacroGenics SWOT Analysis
Table 27. MacroGenics Pediatric Neuroblastoma Treatment Product and Solutions
Table 28. MacroGenics Pediatric Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Pfizer Corporate Information, Location and Competitors
Table 30. Pfizer Pediatric Neuroblastoma Treatment Major Business
Table 31. Pfizer Pediatric Neuroblastoma Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Pfizer SWOT Analysis
Table 33. Pfizer Pediatric Neuroblastoma Treatment Product and Solutions
Table 34. Pfizer Pediatric Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Cellectar Biosciences Corporate Information, Location and Competitors
Table 36. Cellectar Biosciences Pediatric Neuroblastoma Treatment Major Business
Table 37. Cellectar Biosciences Pediatric Neuroblastoma Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Cellectar Biosciences SWOT Analysis
Table 39. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product and Solutions
Table 40. Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Baxter Corporate Information, Location and Competitors
Table 42. Baxter Pediatric Neuroblastoma Treatment Major Business
Table 43. Baxter Pediatric Neuroblastoma Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Baxter SWOT Analysis
Table 45. Baxter Pediatric Neuroblastoma Treatment Product and Solutions
Table 46. Baxter Pediatric Neuroblastoma Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) by Players (2015-2020)
Table 48. Global Pediatric Neuroblastoma Treatment Revenue Share by Players (2015-2020)
Table 49. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Regions (2015-2020)
Table 51. North America Pediatric Neuroblastoma Treatment Revenue by Countries (2015-2020)
Table 52. North America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Table 53. Europe Pediatric Neuroblastoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Pediatric Neuroblastoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Pediatric Neuroblastoma Treatment Revenue by Countries (2015-2020)
Table 56. South America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Pediatric Neuroblastoma Treatment Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Table 59. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) by Type (2015-2020)
Table 60. Global Pediatric Neuroblastoma Treatment Revenue Share by Type (2015-2020)
Table 61. Global Pediatric Neuroblastoma Treatment Revenue Forecast by Type (2021-2025)
Table 62. Global Pediatric Neuroblastoma Treatment Revenue by Application (2015-2020)
Table 63. Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2015-2020)
Table 64. Global Pediatric Neuroblastoma Treatment Revenue Forecast by Application (2021-2025)
Table 65. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pediatric Neuroblastoma Treatment Picture
Figure 2. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type in 2019
Figure 3. Immunotherapy Picture
Figure 4. Chemotherapy Picture
Figure 5. Others Picture
Figure 6. Pediatric Neuroblastoma Treatment Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Pediatric Neuroblastoma Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Pediatric Neuroblastoma Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Pediatric Neuroblastoma Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Pediatric Neuroblastoma Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2019
Figure 43. China Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Pediatric Neuroblastoma Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Pediatric Neuroblastoma Treatment Revenue Share by Type in 2019
Figure 60. Global Pediatric Neuroblastoma Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 62. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Others Revenue Growth Rate (2015-2020)
Figure 64. Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2015-2020)
Figure 65. Global Pediatric Neuroblastoma Treatment Revenue Share by Application in 2019
Figure 66. Global Pediatric Neuroblastoma Treatment Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Pediatric Neuroblastoma Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Pediatric Neuroblastoma Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
成人・小児用血液濃縮器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Adult and Pediatric Hemoconcentrators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.8% in the forecast period of 2020 to 2025 and will expected to reach USD 10470 million by 2025, from USD 9750.4 million in 2019. The…- 小児用歩行器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pediatric Rollator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pediatric Rollator market …
- 小児用頚部カラーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pediatric Cervical Collar market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pediatric Cervical …
- 小児医療の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pediatric Healthcare market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.5% in the forecast period of 2020 to 2025 and will expected to reach USD 152720 million by 2025, from USD 132870 million in 2019. The Pediatr…
- 小児鼻洗浄器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pediatric Nasal Irrigator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pediatric Nasal Irr…